Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.

Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H, et al.

J Clin Oncol. 1986 May;4(5):744-52.

PMID:
3517244
2.

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al.

Blood. 1995 Apr 15;85(8):2025-37.

3.

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.

Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Uckun FM, Bleyer WA.

Cancer. 1998 Feb 1;82(3):600-12.

PMID:
9452280
4.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
5.

Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.

Falletta JM, Shuster JJ, Crist WM, Pullen DJ, Borowitz MJ, Wharam M, Patterson R, Foreman E, Vietti TJ.

Leukemia. 1992 Jun;6(6):541-6.

PMID:
1602793
6.

Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.

Buchanan GR, Boyett JM, Pollock BH, Smith SD, Yanofsky RA, Ghim T, Wharam MD, Crist WM, Vietti TJ, Johnson W, et al.

Cancer. 1991 Jul 1;68(1):48-55.

8.
9.
10.

Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.

Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A; BFM-Group..

Ann Hematol. 2001;80 Suppl 3:B73-6.

PMID:
11757713
11.

Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.

Sackmann Muriel F, Svarch E, Pavlovsky S, Bustelo P, Giuntoli J, Vergara B, Garay G, Eppinger-Helft M, Kvicala R, Dibar E.

Cancer Treat Rep. 1984 Apr;68(4):581-6.

PMID:
6370428
12.

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.

Vora A, Goulden N, Mitchell C, Hancock J, Hough R, Rowntree C, Moorman AV, Wade R.

Lancet Oncol. 2014 Jul;15(8):809-18. doi: 10.1016/S1470-2045(14)70243-8. Epub 2014 Jun 9.

PMID:
24924991
13.

[Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)].

Ortega JJ, Javier G, Montagut JM, Torán N.

An Esp Pediatr. 1986 Feb;24(2):87-97. Spanish.

PMID:
3516041
14.

[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].

Chybicka A, Bogusławska-Jaworska J, Gorczyńska E, Juszczak K, Armata J, Balcerska A, Balwierz W, Bubała H, Filiks-Litwin B, Kołecki P, Kowalczyk J, Lukowska K, Matysiak M, Rokicka-Milewska R, Rola-Kurc E, Stencel D, Sońta-Jakimczyk D, Strojny W, Wachowiak J, Wieczorek M, Wysocki M, Zelenay E.

Wiad Lek. 1998;51 Suppl 4:25-32. Polish.

PMID:
10731940
15.

Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.

Belasco JB, Luery N, Scher C.

Cancer. 1990 Dec 15;66(12):2492-7.

16.

Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.

Leahey AM, Bunin NJ, Belasco JB, Meek R, Scher C, Lange BJ.

Med Pediatr Oncol. 2000 May;34(5):313-8.

PMID:
10797352
17.
18.

Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.

Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.

Haematologica. 1998 Sep;83(9):791-9.

19.

Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.

Chiu EK, Chan LC, Liang R, Lie A, Kwong YL, Todd D, Chan TK.

Leukemia. 1994 Sep;8(9):1469-73.

PMID:
8090027
20.

Supplemental Content

Support Center